We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our
Privacy Policy
.
Yes, I accept
Menu
Corporate Members
E-Library
Twitter
Linked In
Facebook
Instagram
Join
MyESTRO
Search Opener
Search for:
About ESTRO
Membership
School
Workshops
Congresses
Science
Education
Advocacy
Corporate Members
E-Library
Home
Congresses
ESTRO 2026
Programme
Upper GI malignancies
15 May 2026 - 19 May 2026
Stockholm, Sweden
ESTRO 2026
Session
Monday
May 18
16:45 - 17:00
Poster Area
Upper GI malignancies
Session Type:
Poster Highlights
Track:
Clinical
Journey:
Add to
My Programme
A Study on Preoperative pCR Prediction in Esophageal Cancer Patients Using Longitudinal CT Images and Chain-of-Thought Prompt Learning
Presenter
:
QIFENG WANG
,
China
Presentation Number:
-182
Ten year real-world analysis of Stereotactic Body Radiation Therapy (SBRT) in the management of hepatocellular carcinoma
Presenter
:
Veronica Vernier
,
Italy
Presentation Number:
-3169
CBCT-based Online Adaptive RadioTherapy for Esophageal Cancer (ARTEC): Preliminary Results of a Prospective Single-Center Study
Presenter
:
Nicolas Bachmann
,
Switzerland
Presentation Number:
-3726
Clinical outcomes of adaptive MRI-guided stereotactic body radiation therapy for pancreatic cancer in a 169-patient cohort
Presenter
:
Pia Hartfelt
,
Denmark
Presentation Number:
-4170
Target dose deposition and tumor control in proton therapy for distal esophageal cancer
Presenter
:
Kyra van Keeken
,
The Netherlands
Presentation Number:
-4302
high coronary artery calcification is associated with cardiovascular events in oesophageal cancer patients undergoing thoracic radiotherapy
Presenter
:
Renliang Xue
,
The Netherlands
Presentation Number:
-4408
Spared Lung Volume as a Novel Predictor of Postoperative Respiratory Failure in Esophageal Cancer
Presenter
:
Yuting Liu
,
Belgium
Presentation Number:
-4905
Radiotherapy combined with chemoimmunotherapy in gastric cancer with limited lymph node metastases: Preliminary results of the MIRACLE-G study
Presenter
:
Wang Yang
,
China
Presentation Number:
-789
Phase II study of envafolimab combined with endostar and concurrent chemoradiotherapy in treatment of unresectable locally advanced ESCC
Presenter
:
Qian Zhao
,
China
Presentation Number:
-1212
The Burden of Radiotherapy on Future Vascular Risk in Esophageal Cancer: A Real-World Evidence Study
Presenter
:
Jeng-You Wu
,
Taiwan, Province of China
Presentation Number:
-1873
Multicenter Analysis of Pancreatic SBRT in 356 Patients: Clinical Outcomes, Treatment-Related Effects, and Imaging Response Across Italian Centers
Presenter
:
Rita Marina Niespolo
,
Italy
Presentation Number:
-1906
Preliminary clinical outcomes from a single-institution phase II study of stereotactic body radiotherapy for hepatocellular carcinoma in Chile
Presenter
:
Pablo Munoz Schuffenegger
,
Chile
Presentation Number:
-2561
Time-of-day effects of neoadjuvant chemoradiotherapy on pathologic complete response and lymphopenia in patients with esophageal cancer
Presenter
:
David Qian
,
USA
Presentation Number:
-2594
Dose escalation of definitive chemoradiotherapy in Asian patients with esophageal cancer: a retrospective cohort study
Presenter
:
Shuo-Fu Chen
,
Taiwan, Province of China
Presentation Number:
-3146
E-Mail Address
Please enter a user name
Password
Cancel
Forgotten Password
Create MyESTRO Account
i
Please log in to add this session to your programme.